Patents by Inventor Nicholas D. WEBER

Nicholas D. WEBER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200385721
    Abstract: The present invention provides lipid particles comprising therapeutic nucleic acids such as gRNA that target gene expression.
    Type: Application
    Filed: March 16, 2020
    Publication date: December 10, 2020
    Applicant: ARBUTUS BIOPHARMA CORPORATION
    Inventors: Amy C. H. LEE, Nicholas D. WEBER
  • Patent number: 10626393
    Abstract: The present invention provides lipid particles comprising therapeutic nucleic acids such as gRNA that target gene expression.
    Type: Grant
    Filed: June 6, 2016
    Date of Patent: April 21, 2020
    Assignee: ARBUTUS BIOPHARMA CORPORATION
    Inventors: Amy C. H. Lee, Nicholas D. Weber
  • Publication number: 20180245074
    Abstract: The present invention provides compositions comprising therapeutic nucleic acids such as gRNA that target Hepatitis B virus (HBV) gene expression, lipid particles comprising one or more (e.g., a combination) of the therapeutic nucleic acids, and methods of delivering and/or administering the lipid particles (e.g., for treating HBV infection and/or HDV infection in humans).
    Type: Application
    Filed: June 6, 2016
    Publication date: August 30, 2018
    Applicant: PROTIVA BIOTHERAPEUTICS, INC.
    Inventors: Amy C. H. LEE, Nicholas D. WEBER
  • Publication number: 20180148719
    Abstract: The present invention provides lipid particles comprising therapeutic nucleic acids such as gRNA that target gene expression.
    Type: Application
    Filed: June 6, 2016
    Publication date: May 31, 2018
    Applicant: PROTIVA BIOTHERAPEUTICS, INC.
    Inventors: Amy C. H. LEE, Nicholas D. WEBER